Search by Drug Name or NDC

    NDC 50228-0452-05 ATORVASTATIN CALCIUM 20 mg/1 Details

    ATORVASTATIN CALCIUM 20 mg/1

    ATORVASTATIN CALCIUM is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ScieGen Pharmaceuticals, Inc.. The primary component is ATORVASTATIN CALCIUM TRIHYDRATE.

    Product Information

    NDC 50228-0452
    Product ID 50228-452_09acadb7-c0a4-d753-e063-6294a90af9a9
    Associated GPIs 39400010100320
    GCN Sequence Number 029968
    GCN Sequence Number Description atorvastatin calcium TABLET 20 MG ORAL
    HIC3 M4D
    HIC3 Description ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS)
    GCN 43721
    HICL Sequence Number 012404
    HICL Sequence Number Description ATORVASTATIN CALCIUM
    Brand/Generic Generic
    Proprietary Name ATORVASTATIN CALCIUM
    Proprietary Name Suffix n/a
    Non-Proprietary Name ATORVASTATIN CALCIUM
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name ATORVASTATIN CALCIUM TRIHYDRATE
    Labeler Name ScieGen Pharmaceuticals, Inc.
    Pharmaceutical Class HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205519
    Listing Certified Through 2024-12-31

    Package

    NDC 50228-0452-05 (50228045205)

    NDC Package Code 50228-452-05
    Billing NDC 50228045205
    Package 500 TABLET, FILM COATED in 1 BOTTLE (50228-452-05)
    Marketing Start Date 2016-05-19
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.04112
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ATORVASTATIN 20 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis